- Home
- BEDU vs RNXT Comparison
BEDU vs RNXT Comparison
Compare BEDU & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEDU
- RNXT
- Stock Information
- Founded
- BEDU 1994
- RNXT 2012
- Country
- BEDU United Kingdom
- RNXT United States
- Employees
- BEDU N/A
- RNXT N/A
- Industry
- BEDU Other Consumer Services
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- BEDU Real Estate
- RNXT Health Care
- Exchange
- BEDU Nasdaq
- RNXT Nasdaq
- Market Cap
- BEDU 54.0M
- RNXT 44.6M
- IPO Year
- BEDU 2017
- RNXT 2021
- Fundamental
- Price
- BEDU $1.85
- RNXT $1.27
- Analyst Decision
- BEDU
- RNXT Strong Buy
- Analyst Count
- BEDU 0
- RNXT 2
- Target Price
- BEDU N/A
- RNXT $7.25
- AVG Volume (30 Days)
- BEDU 2.3K
- RNXT 117.8K
- Earning Date
- BEDU 08-01-2025
- RNXT 08-14-2025
- Dividend Yield
- BEDU N/A
- RNXT N/A
- EPS Growth
- BEDU N/A
- RNXT N/A
- EPS
- BEDU N/A
- RNXT N/A
- Revenue
- BEDU $224,321,752.00
- RNXT $240,000.00
- Revenue This Year
- BEDU N/A
- RNXT $3,104.65
- Revenue Next Year
- BEDU N/A
- RNXT $301.89
- P/E Ratio
- BEDU N/A
- RNXT N/A
- Revenue Growth
- BEDU N/A
- RNXT N/A
- 52 Week Low
- BEDU $1.35
- RNXT $0.75
- 52 Week High
- BEDU $2.41
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- BEDU 58.50
- RNXT 45.64
- Support Level
- BEDU $1.76
- RNXT $1.23
- Resistance Level
- BEDU $1.91
- RNXT $1.35
- Average True Range (ATR)
- BEDU 0.05
- RNXT 0.06
- MACD
- BEDU 0.01
- RNXT -0.01
- Stochastic Oscillator
- BEDU 63.89
- RNXT 23.53
About BEDU Bright Scholar Education Holdings Limited each representing four
Bright Scholar Education Holdings Ltd operates as an education service provider. It is engaged in the provision of education services, including complementary education services, operation services for domestic schools, and education programs and services including independent schools and colleges in United Kingdom (the UK) and the United States (the U.S.) Kingdom. It nearly eight overseas school located in the United Kingdom and the United States. It has three reportable segments, including Overseas Schools, Complementary Education Services, and K-12 Operation Services. Key revenue is generated from Overseas Schools. From a geographical perspective: Key revenue is generated from China following UK, U.S., Canada and Singapore.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.